Commercialization and Protection of Biotech Products in Singapore and Malaysia: Linking Intellectual Property Rights with Economic Performance

Danilo Jamróz
Department of Life Sciences and Systems Biology, University of Torino, Torino, Italy.
Ewelina Ciaramella
Department of Botany, Physiology and Plant Protection, Faculty of Biotechnology and Horticulture, University of Agriculture in Krakow, Krakow, Poland.

DOI:https://doi.org/10.5912/jcb1895

Abstract:

The present study evaluated the impact of commercialization (CM) and intellectual property rights (IPR) on economic performance (EP) in the biotech sector of Malaysia and Singapore. A quantitative approach was deemed suitable to examine the linkages among the variables. Through a non-probability sampling technique, the researcher obtained data from 201 managerial-level employees. Data were statistically analyzed through regression analysis. The findings of the study revealed that a significant association exists between CM and EP. Similarly, the relationship between IPR and EP was found to be positive and significant. The research adds significant knowledge to the existing literature on IPR and commercialization in the biotech industry. Furthermore, it provides implications for practitioners to enhance their economic performance through increased patents and technological commercialization. Finally, the limitations and future research recommendations are discussed.